Surgical Design Studios
The Insides Company is dedicated to revolutionizing the treatment of intestinal catastrophes through innovative medical devices and therapies, including chyme reinfusion therapy. With a mission to provide universal access to these breakthrough solutions, the company leverages over 30 years of clinical experience to improve patient outcomes and set new standards in healthcare. The company is a global leader in chyme reinfusion therapeutic medical devices, with a focus on patients suffering from high-output proximal enterostomy or enterocutaneous fistula. It has received ISO 13485 certification, CE marking, and achieved carbon-neutral status, demonstrating its commitment to quality and environmental sustainability.
Industries
Nr. of Employees
small (1-50)
Surgical Design Studios
487 Parnell Road, Auckland, 1052, New Zealand
Products
Automated chyme reinfusion system (adult)
Medical device platform that automates collection and reinfusion of intestinal chyme to restore enteral nutrient flow and reduce dependence on parenteral nutrition in adult patients with enterostomies or fistulas.
Neonatal chyme reinfusion device and adapter set
Device variant and accessory set adapted for neonatal and pediatric patients to support intestinal recovery and nutrition in neonatal intensive care settings, with consumables and connectors sized for neonatal physiology.
Accessory components for ostomy and fistula management
Accessory components designed to interface with reinfusion platforms to enable use in patients with separated ostomies, fistulas or varied stoma anatomies.
Device firmware and driver release packages
Versioned firmware and driver updates for device platforms to improve performance, usability and safety, with publicised release notes and version tracking.
Automated chyme reinfusion system (adult)
Medical device platform that automates collection and reinfusion of intestinal chyme to restore enteral nutrient flow and reduce dependence on parenteral nutrition in adult patients with enterostomies or fistulas.
Neonatal chyme reinfusion device and adapter set
Device variant and accessory set adapted for neonatal and pediatric patients to support intestinal recovery and nutrition in neonatal intensive care settings, with consumables and connectors sized for neonatal physiology.
Accessory components for ostomy and fistula management
Accessory components designed to interface with reinfusion platforms to enable use in patients with separated ostomies, fistulas or varied stoma anatomies.
Device firmware and driver release packages
Versioned firmware and driver updates for device platforms to improve performance, usability and safety, with publicised release notes and version tracking.
Services
Appointment and management of exclusive regional distributors and logistics partners to supply devices and consumables across multiple countries and regions.
Provision of on-demand training content, instructional videos, IFUs and in-person/event-based sessions to teach clinical use of reinfusion therapy and associated device workflows.
Operation of an observational clinical registry that collects pseudo-anonymised patient data to identify outcome trends, support publications and fulfil post-market surveillance obligations.
Partnerships with academic and clinical research groups to run feasibility studies, first‑patient‑in milestones and randomized trials, including device provision and trial facilitation.
Dedicated clinical and technical support channels for healthcare providers and distributors, including clinical advice, troubleshooting, product returns handling and distributor coordination.
Provision of downloadable brochures, IFUs, instructional videos, posters, case reports and clinical publications to support clinician education and evidence dissemination.
Appointment and management of exclusive regional distributors and logistics partners to supply devices and consumables across multiple countries and regions.
Provision of on-demand training content, instructional videos, IFUs and in-person/event-based sessions to teach clinical use of reinfusion therapy and associated device workflows.
Operation of an observational clinical registry that collects pseudo-anonymised patient data to identify outcome trends, support publications and fulfil post-market surveillance obligations.
Partnerships with academic and clinical research groups to run feasibility studies, first‑patient‑in milestones and randomized trials, including device provision and trial facilitation.
Dedicated clinical and technical support channels for healthcare providers and distributors, including clinical advice, troubleshooting, product returns handling and distributor coordination.
Provision of downloadable brochures, IFUs, instructional videos, posters, case reports and clinical publications to support clinician education and evidence dissemination.
Expertise Areas
- Chyme reinfusion therapy and enteral nutrient recycling
- Intestinal failure management and enteral nutrition strategies
- Neonatal and pediatric intestinal rehabilitation
- Medical device design, human factors and industrial design
Key Technologies
- Automated chyme reinfusion systems
- Embedded device firmware and drivers
- Cloud-hosted clinical registries with encryption
- Pseudo-anonymisation and data governance for registries
News & Updates
The Insides Company appointed Medella S.A. as its exclusive distribution partner in Greece to introduce chyme reinfusion therapy.
The Insides Company announced the registration of The Insides Neo in Australia.
The Insides System received the 2021 MTANZ Innovation Award for medical technology.
The Insides System and Neo received CE Mark certification under EU MDR.
A case study on The Insides System published in the Colorectal Disease journal.
Recognition of Professor Gil Hardy for his contributions to nutrition and intestinal failure management.
The Insides Company appointed Medella S.A. as its exclusive distribution partner in Greece to introduce chyme reinfusion therapy.
The Insides Company announced the registration of The Insides Neo in Australia.
The Insides System received the 2021 MTANZ Innovation Award for medical technology.
The Insides System and Neo received CE Mark certification under EU MDR.
A case study on The Insides System published in the Colorectal Disease journal.
Recognition of Professor Gil Hardy for his contributions to nutrition and intestinal failure management.